Novel Treatments Expand Second-Line Options in ITP
Published: Friday, May 22, 2020
Ivy P. Altomare, MD
Although steroids remain the standard frontline treatment for patients with immune thrombocytopenia (ITP), the armamentarium in the second-line setting is rapidly expanding, according to Ivy P. Altomare, MD.
... to read the full story